$MNKD Headlines MannKind shares climb 3.9% in early

New Post Public Reply Private Reply Replies (0) Message Board

Jan 28, 2015 at 10:24 AM

$MNKD Headlines

MannKind shares climb 3.9% in early trade 37 min ago - Silvia Ascarelli
Skullcandy gains on upgrade,Tesla reverses gains 1:37 p.m. Aug. 12, 2014 - Sue Chang
U.S. small caps lead broad stock-market gains 3:09 p.m. Aug. 11, 2014 - Anora Mahmudova
Kinder Morgan soars, Tesla rallies on upgrade 11:46 a.m. Aug. 11, 2014 - Sue Chang
MannKind shares soar on Sanofi deal; investors ignore earnings report 9:10 a.m. Aug. 11, 2014 - Russ Britt
Super-Moon illusion or buy the dips on this stock market? 6:52 a.m. Aug. 11, 2014 - Barbara Kollmeyer
MannKind shares soar 23% on Sanofi deal over Afrezza 6:04 a.m. Aug. 11, 2014 - Silvia Ascarelli
Sanofi, MannKind to commercialize Afrezza insulin therapy 4:32 a.m. Aug. 11, 2014 - Silvia Ascarelli
Puma Biotech’s blast-off is not a typical short squeeze 11:10 a.m. July 23, 2014 - Tomi Kilgore
S&P 500 posts strongest 2nd quarter since 2009: Stock market live blog recap 2:33 p.m. June 30, 2014 - blogs.marketwatch.com
MannKind, GoPro rise; Yahoo gains on upgrade 11:02 a.m. June 30, 2014 - Sue Chang
MannKind shares up 23.1% in premarket trade 6:19 a.m. June 30, 2014 - Ciara Linnane
Six more bull months ahead, and GoPro keeps on going 5:28 a.m. June 30, 2014 - Sara Sjolin
MannKind wins approval for its inhaled insulin — and its stock drops? 3:30 p.m. June 27, 2014 - Russ Britt
DuPont falls on outlook; Michaels debuts 3:08 p.m. June 27, 2014 - Sue Chang
3 overlooked stocks loved by top-ranked advisers 2:09 p.m. April 25, 2014 - Mark Hulbert
Tesla, Facebook seesaw; Questcor surges on deal 2:54 p.m. April 7, 2014 - Sue Chang
MannKind drops after FDA says its review on drug will last until July 12:46 p.m. April 7, 2014 - Russ Britt
Stock futures drop as earnings season looms 8:20 a.m. April 7, 2014 - Sara Sjolin
MannKind drops 12% after FDA review extension 6:15 a.m. April 7, 2014 - Ben Eisen

The 5 Most Shorted Nasdaq Stocks in Early January 5:56 a.m. Today - 247WallSt.com
Biggest Movers in Healthcare Stocks Now – ARIA MYGN NVS MNKD 5:30 a.m. Jan. 27, 2015 - InvestorPlace.com
Another Reason MannKind Could Be Up (In 1 Tweet) 3:15 p.m. Jan. 26, 2015 - benzinga.com
A New Price Estimate Now That Afrezza Is Launching 8:58 a.m. Jan. 26, 2015 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – LCI HCA MNKD INCY 5:45 a.m. Jan. 26, 2015 - InvestorPlace.com
Cramer's Lightning Round - The Blackstone Group Is The Best PE Company (1/22/15) 8:18 a.m. Jan. 23, 2015 - Seeking Alpha
MNKD: Afrezza Launch Will Propel MannKind Stock 8:00 a.m. Jan. 23, 2015 - InvestorPlace.com
'Mad Money' Lightning Round: Altria's Stock Is Still Good 6:00 a.m. Jan. 23, 2015 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Here Are More Reasons to Buy U.S. Stocks 8:26 p.m. Jan. 22, 2015 - TheStreet.com
Hottest Healthcare Stocks Now – ALNY MNKD WOOF DGX 12:45 p.m. Jan. 22, 2015 - InvestorPlace.com
The Real News About Afrezza From The JPMorgan Conference 11:58 a.m. Jan. 20, 2015 - Seeking Alpha
Seeking Alpha's Biotech Weekly: Roche Takes Control, Shire's A Buyer, And More 4:00 p.m. Jan. 16, 2015 - Seeking Alpha
Short Interest in Biotechs Signals Optimism 7:58 a.m. Jan. 13, 2015 - 247WallSt.com
Watch MannKind Closely, A Short Squeeze Could Be Nearing 7:37 a.m. Jan. 13, 2015 - Seeking Alpha
The 5 Most Shorted Nasdaq Stocks at the End of 2014 6:51 a.m. Jan. 13, 2015 - 247WallSt.com
Why The New MannKind Management Could Focus On R&D, Not A Potential Sanofi Merger 2:44 p.m. Jan. 12, 2015 - benzinga.com
MannKind Gets Little Love From Sanofi at 'JPM15' Presentation 1:35 p.m. Jan. 12, 2015 - TheStreet.com
MannKind Appoints Edstrom CEO 8:01 a.m. Jan. 12, 2015 - The Wall Street Journal Interactive Edition
MannKind Founder Becomes Chairman, President Hakan Edstrom Becomes New CEO 7:26 a.m. Jan. 12, 2015 - benzinga.com
Update: A Dangerous Time To Be Short MannKind 5:17 a.m. Jan. 12, 2015 - Seeking Alpha

Critical Alerts For Transocean, MannKind, Twitter, iRobot and Micron Released By InvestorsObserver 9:31 a.m. Jan. 26, 2015 - PR Newswire - PRF
MannKind CEO Alfred Mann to Transition to Executive Chairman; COO and President Hakan Edstrom Appointed to CEO 9:21 p.m. Jan. 12, 2015 - GlobeNewswire
Critical Alerts For Kinder Morgan, Halozyme Therapeutics, MannKind, BP and Union Pacific Released By InvestorsObserver 9:31 a.m. Jan. 8, 2015 - PR Newswire - PRF
MannKind Earns $50 Million in Milestone Payments From Sanofi 7:01 a.m. Jan. 8, 2015 - GlobeNewswire
MannKind Corporation to Present at the J.P. Morgan 2015 Healthcare Conference 5:01 p.m. Jan. 7, 2015 - GlobeNewswire
Technical Report on Biotech Stocks -- MannKind, Amgen, Celldex Therapeutics, Juno Therapeutics, and Ironwood Pharma 8:35 a.m. Dec. 31, 2014 - PR Newswire - PRF
Critical Alerts For MannKind, Merck, Alnylam Pharmaceuticals, Nu Skin Enterprises and Organovo Released By InvestorsObserver 9:31 a.m. Dec. 9, 2014 - PR Newswire - PRF
MannKind Corporation to Present at The 26th Annual Piper Jaffray Healthcare Conference 5:00 p.m. Nov. 25, 2014 - GlobeNewswire
Critical Alerts For MannKind, CyberArk Software, Best Buy, Nordstrom and ExOne Released By InvestorsObserver 9:31 a.m. Nov. 14, 2014 - PR Newswire - PRF
Equity Coverage on Biotech Industry - Gilead Sciences, MannKind, ARIAD Pharma, iBio Inc., and Celgene 9:10 a.m. Nov. 14, 2014 - PR Newswire - PRF
Insider Trading Buzz for SolarCity, RF Micro Devices, Ford Motor, MannKind, Plug Power, and GoPro 8:45 a.m. Nov. 7, 2014 - PR Newswire - PRF
MannKind Corporation Reports 2014 Third Quarter Financial Results 9:01 a.m. Nov. 3, 2014 - GlobeNewswire
Insider Trading Buzz for Twitter, Delta Air Lines, Apple, GoPro, GT Advanced Technologies, and MannKind 7:45 a.m. Oct. 28, 2014 - PR Newswire - PRF
MannKind Corporation to Hold 2014 Third Quarter Financial Results Conference Call on November 3, 2014 4:01 p.m. Oct. 27, 2014 - GlobeNewswire
Earnings Forecast Research for DryShips, GoPro, Gilead Sciences, MannKind, GT Advanced Technologies, and Amazon 7:45 a.m. Oct. 27, 2014 - PR Newswire - PRF
Critical Alerts For MannKind, Alibaba, Yahoo!, El Pollo Loco and Activision Blizzard Released By InvestorsObserver 8:31 a.m. Oct. 23, 2014 - PR Newswire - PRF
Insider Trading Alerts for Micron, CSX, Ariad Pharmaceuticals, IBM, SinoCoking Coal and Coke Chemical, and MannKind 7:55 a.m. Oct. 21, 2014 - PR Newswire - PRF
Insider Trading Research for Halliburton, Ariad Pharmaceuticals, KeyCorp, GoPro, MannKind, and Plug Power 7:45 a.m. Oct. 20, 2014 - PR Newswire - PRF
Earnings Forecast Alerts for Apple, Intel, MannKind, GoPro, Plug Power, and Cliffs Natural Resources 7:45 a.m. Oct. 16, 2014 - PR Newswire - PRF
Latest Insider Trading for FuelCell Energy, Flextronics, MannKind, GT Advanced Technologies, Plug Power, and GoPro 7:55 a.m. Oct. 15, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Innovent's IBI3001 Shows Promise in Phase 1 Trials

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

DIRECTV Bags New NHL Deals: Stakes for Sports Fans

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Firefox Champions Privacy with Iconic Internet Campaign

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

CapCut's Role in AI-Assisted Small Biz Marketing

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Ivonescimab Promises New Hope for Advanced BTC Patients

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...